08 Aug 4Dx Research Breakthrough: Changing the Face of Diagnostic Imaging
The results of a new pre-clinical study, show that 4Dx’s breakthrough four-dimensional lung diagnostic platform has the ability to better measure the progression and severity of cystic fibrosis (CF) like lung disease – something that is critically lacking in today’s care of patients with lung disease.
The significant results have fuelled hopes among clinicians, including Professor Greg Snell, Head of Lung Transplant Service at the Alfred hospital, for major improvement in treating lung disease.
“This technology has great potential as a new tool for both early diagnosis and management of many very common lung conditions. I think this will be the start of a new way of thinking about diagnostic imaging,” says Snell.
Click here to access the full paper.